In vivo activating transcription factor 3 silencing ameliorates the AMPK compensatory effects for ER stress-mediated β-cell dysfunction during the progression of type-2 diabetes. (Q39115085)
Jump to navigation
Jump to search
scientific article published on 2 August 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | In vivo activating transcription factor 3 silencing ameliorates the AMPK compensatory effects for ER stress-mediated β-cell dysfunction during the progression of type-2 diabetes. |
scientific article published on 2 August 2013 |
Statements
In vivo activating transcription factor 3 silencing ameliorates the AMPK compensatory effects for ER stress-mediated β-cell dysfunction during the progression of type-2 diabetes (English)
Ji Yeon Kim
Keun Jae Park
Gyu Hee Kim
Eun Ae Jeong
Dae Yeon Lee
Seong Su Lee
Dae Jin Kim
Sung Hwan Ki